Samsrita Labs Ltd. 2020 AR2
The report outlines the financial and operational performance of Dr Habeebullah Life Sciences Limited for the fiscal year 2019-2020. During the year, the company focused on its core healthcare business, including molecular diagnostics, stem cell research, and outpatient services. Despite operational challenges due to the COVID-19 pandemic, the company continued its research and development efforts, particularly in biotechnology and molecular diagnostics. The company also progressed with its subsidiary, Krisani Bio Sciences Private Limited, which holds multiple international patents for treating rare diseases.
Company: Samsrita Labs Ltd.
Sector: Healthcare & social services
Country: India
Year: 2020
Type: AR2
Pages: 149
Back to company
Samsrita Labs Ltd.
Annual Report
The report outlines the financial and operational performance of Dr Habeebullah Life Sciences Limited for the fiscal year 2019-2020. During the year, the company focused on its core healthcare business, including molecular diagnostics, stem cell research, and outpatient services. Despite operational challenges due to the COVID-19 pandemic, the company continued its research and development efforts, particularly in biotechnology and molecular diagnostics. The company also progressed with its subsidiary, Krisani Bio Sciences Private Limited, which holds multiple international patents for treating rare diseases.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 1, 2019 - Mar 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees